Menu

All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

SHOW SEARCH

Pulmonary Arterial Hypertension: Meeting Critical Care Needs

Thursday, July 16, 2020, 12:00 PM - 1:00 PM CT  -  Register to attend July 16
 

 

Activity Description

This activity will focus on foundational PAH knowledge including signs and symptoms, etiology, treatment, and patient education. The format will utilize a patient case presentation to highlight therapeutic approaches to manage PAH with a focus on critical care management. The session will cover insights into PAH pathophysiology, PAH therapies and the most recent data surrounding their uses, clinical guidelines, and optimal management during transitions of care. Opportunities for nurses to use patient-centered care approaches during transitions of care including cost management, anticipated side effects, the importance of adherence will also be discussed.

Learning Objectives

The target audience for this activity includes nurses and pharmacists. At the completion of this activity, the participant will be able to:

  • Discuss the revised definition, classification, and diagnostic algorithm for pulmonary arterial hypertension (PAH).
  • Discuss the revised treatment algorithm for PAH and the 3 treatment pathways.
  • Outline nursing methods to improve adherence in PAH through careful medication titration and side effect management.

Faculty

Martha Kingman, DNP, FNP-C
Nurse Practitioner
Pulmonary Hypertension Comprehensive Care Center
University of Texas Southwestern Medical Center at Dallas

CE Accreditation

Pharmacists

ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-20-297-L01-P has been assigned to this live knowledge-based activity (initial release date 7-16-2020). This activity is approved for 1.0 contact hours (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.

Nurses(Pharmacology Credit)

This CE activity is jointly provided by ProCE, Inc. and Wild Iris Medical Education, Inc. This activity provides 1.0 contact hour of nurse CE credit.

Wild Iris Medical Education, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Martha Kingman is an advisory Board Member for Actelion, Bayer, United Therapeutics, and Liquidia and a consultant for Actelion, Bayer, and Liquidia.

Funding

This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc.

    

Webinar Equipment Requirements
-Computer with broadband Internet access
-Soundcard and speakers or headphones for your computer (or dial-in via telephone for audio)
Click here for detailed software requirements.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.